Loma Linda University School of Public Health, Department of Nutrition

An award with merit: Loma Linda University recognizes IEHP's Jarrod McNaughton for stellar service

Retrieved on: 
Monday, June 26, 2023
Linda, Loma Linda University, Awards and decorations of the Civil Air Patrol, Doctor of Public Health, Medicaid, Texas Meritorious Service Award, Rancho, Medicare, Inland Empire, Public health, Patient, School, Loma Linda University School of Public Health, Department of Nutrition, McNaughton, Nursing, MD

RANCHO CUCAMONGA, Calif., June 26, 2023 /PRNewswire/ -- Inland Empire Health Plan's (IEHP) Chief Executive Officer Jarrod McNaughton is Loma Linda University's 2023 Meritorious Service Award recipient.

Key Points: 
  • RANCHO CUCAMONGA, Calif., June 26, 2023 /PRNewswire/ -- Inland Empire Health Plan's (IEHP) Chief Executive Officer Jarrod McNaughton is Loma Linda University's 2023 Meritorious Service Award recipient.
  • McNaughton – who has served as CEO since 2019 – formally accepted the award during the university's School of Public Health commencement ceremony held Friday, June 9.
  • McNaughton earned the award for his commitment to lead with integrity in fulfilling IEHP's mission "to heal and inspire the human spirit," university officials stated.
  • "I am thrilled to receive Loma Linda's prestigious Meritorious Service Award," McNaughton said.

APhA Select Permanent CEO

Retrieved on: 
Thursday, April 27, 2023
Linda, BCPS, Doctor of Pharmacy, Loma Linda University School of Public Health, Department of Nutrition, Senior, Policy, Multimedia, Pharmacist, American Pharmacists Association, JD, School, Management, Pharmacy, Medicine

WASHINGTON, April 27, 2023 /PRNewswire/ -- Today, the American Pharmacists Association (APhA) announced that Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, has been named the 15th Chief Executive Officer and Executive Vice President of APhA.

Key Points: 
  • WASHINGTON, April 27, 2023 /PRNewswire/ -- Today, the American Pharmacists Association (APhA) announced that Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, has been named the 15th Chief Executive Officer and Executive Vice President of APhA.
  • He previously served as APhA President in 2020–2021, is well known nationally and internationally for his work with vaccine policy and has extensive experience as an independent and ambulatory care pharmacy practice innovator.
  • "We are thrilled to announce Michael Hogue as the next CEO/EVP of the American Pharmacists Association," said Valerie Prince, PharmD, BCPS, FAPhA, President of APhA.
  • APhA is deeply grateful to Ilisa Bernstein, PharmD, JD, FAPhA, interim executive vice president and CEO, for her leadership of APhA during this time of transition.

Children’s Hospital Los Angeles Appoints Lara Khouri as Chief Operating Officer

Retrieved on: 
Wednesday, March 29, 2023
Science, Research, General Health, Health, Children, Family, Hospitals, Consumer, Columbia University, Loma Linda University School of Public Health, Department of Nutrition, Transformation, Columbia University Mailman School of Public Health, Pediatrics, Hospital, CHLA, Heart, COVID-19, Public, Hope, MBA, Multimedia, History, Bangladesh Technical Education Board, Organization, Business administration, Public health, Gold, American Hospital Association, DHCS, Patient, Nursing, Children's Hospital Los Angeles, Child, Khouri, Growth, Policy, Master of Business Administration, MPH, George Washington University, Economics, Female, Geography, Management, Orthopedic surgery, Cancer, Neuroscience, Woman

Children’s Hospital Los Angeles (CHLA) has appointed Lara Khouri , MBA, MPH, to be Executive Vice President and Chief Operating Officer (COO).

Key Points: 
  • Children’s Hospital Los Angeles (CHLA) has appointed Lara Khouri , MBA, MPH, to be Executive Vice President and Chief Operating Officer (COO).
  • View the full release here: https://www.businesswire.com/news/home/20230328005073/en/
    Lara Khouri appointed Executive Vice President and Chief Operating Officer of Children's Hospital Los Angeles.
  • She mostly recently served as Executive Vice President and Chief Strategy and Transformation Officer since December 2020, and has held several other leadership roles during her CHLA tenure.
  • Khouri earned a Master of Business Administration and a Master of Public Health from Columbia University; she has undergraduate degrees in geography and economics from George Washington University.

BridgeBio Pharma Shares Preliminary Findings on Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I)

Retrieved on: 
Tuesday, March 21, 2023
Linda, Creatine kinase, Myopathy, Loma Linda University School of Public Health, Department of Nutrition, Natural history, Ribitol, PALO, Calendar, Loma Linda University, B cell, Month, FKRP, Muscle weakness, Patient, Cancer, Webcast, MDA, Glycosylation, Neurology, NSAD, Disease, Pharmaceutical industry, Medical imaging, Fine chemical

Additionally, BridgeBio shared updated results at Month 15 for its Phase 2 clinical trial and the design for its pivotal Phase 3 study for patients with LGMD2I.

Key Points: 
  • Additionally, BridgeBio shared updated results at Month 15 for its Phase 2 clinical trial and the design for its pivotal Phase 3 study for patients with LGMD2I.
  • The novel bioassay was developed by BridgeBio to measure the amount of glycosylated ⍺DG, and to evaluate the impact of BBP-418 treatment.
  • The bioassay allowed the Company to evaluate natural history and Phase 2 data to inform the Phase 3 study design.
  • If approved, BridgeBio believes BBP-418 could be the first approved orally administered therapy for the treatment of patients with LGMD2I.

BridgeBio Pharma to Present Preliminary Findings on its Novel Bioassay Measuring Glycosylated Alpha-dystroglycan (⍺DG) in Patients with Limb-girdle Muscular Dystrophy Type 2I (LGMD2I)

Retrieved on: 
Friday, March 17, 2023
Linda, Loma Linda University School of Public Health, Department of Nutrition, PALO, Calendar, Loma Linda University, Alpha, Patient, Glycosylation, Cancer, Annual general meeting, Webcast, MDA, Neurology, Pharmaceutical industry

PALO ALTO, Calif., March 17, 2023 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, announced today that preliminary data on the Company’s muscle tissue-based bioassay measuring glycosylated ⍺DG in LGMD2I patients will be featured in an oral presentation and posters at the MDA 2023 Annual Meeting, taking place in Dallas, Texas on March 19 - 22, 2023. BridgeBio will host an investor call with Jeffrey Rosenfeld, M.D., Ph.D., a specialist in neuromuscular medicine and professor of neurology at Loma Linda University School of Medicine on Tuesday, March 21 at 8:30 am ET to discuss the results shared at the meeting.

Key Points: 
  • BridgeBio will host an investor call with Jeffrey Rosenfeld, M.D., Ph.D., a specialist in neuromuscular medicine and professor of neurology at Loma Linda University School of Medicine on Tuesday, March 21 at 8:30 am ET to discuss the results shared at the meeting.
  • BridgeBio was selected to share an oral presentation and posters on its ongoing Phase 2 trial with 15-month results, including the preliminary design of its pivotal Phase 3 study in patients with LGMD2I, which is expected to launch in mid-2023.
  • A link to the webcast may be accessed from the event calendar page of BridgeBio’s website at https://investor.bridgebio.com/ .
  • A replay of the conference call and webcast will be archived on the Company’s website and will be available for at least 30 days following the event.

The American Diabetes Association Announces 2023 Pathway to Stop Diabetes Grant Recipients

Retrieved on: 
Tuesday, January 31, 2023
MD, University of North Carolina at Pembroke, B cell, University, School, Feinberg School of Medicine, Environment, UNC Gillings School of Global Public Health, Obesity, ADA, Health, Pathway, Research, Brain, Diabetes, Chapel Hill, Face, Metabolism, Blood, Swansea University Medical School, Loma Linda University School of Public Health, Department of Nutrition, Division, Doctor of Philosophy, American Diabetes Association, Pharmaceutical industry, Nursing, Medicine, Endocrinology, DRS

ARLINGTON, Va., Jan. 31, 2023 /PRNewswire/ -- Today, the American Diabetes Association® (ADA) announced the two winners of the Pathway to Stop Diabetes® (Pathway) grants, a five-year grant to support breakthroughs in translational science, clinical science, technology, care, and potential cures in the field of diabetes.

Key Points: 
  • ARLINGTON, Va., Jan. 31, 2023 /PRNewswire/ -- Today, the American Diabetes Association® (ADA) announced the two winners of the Pathway to Stop Diabetes® (Pathway) grants, a five-year grant to support breakthroughs in translational science, clinical science, technology, care, and potential cures in the field of diabetes.
  • The ADA is proud to support these individuals and their potential to change the face of diabetes care since 2014.
  • "Our Pathway to Stop Diabetes grants create an environment of success for awardees and provides them with the autonomy, resources, and guidance needed to pioneer the next historic advancement in diabetes care.
  • To learn about past and current Pathway award recipients, visit Pathway to Stop Diabetes.

2022 International Volunteer Service Exchange and Sharing Conference held in Nanjing

Retrieved on: 
Thursday, December 15, 2022
Social media, United States Secretary of Labor, International Volunteer Day, Loma Linda University School of Public Health, Department of Nutrition, Language, Civilization, Conference, Amity Foundation, Communication, International, Seed, Memorial Hall of the Victims in Nanjing Massacre by Japanese Invaders, Normal school, Love, Renmin University of China, History, Multimedia, Memorial hall, Beijing Normal University, Hospital, Volunteering, Motivation, Associate, Tourism

NANJING, China, Dec. 15, 2022 /PRNewswire/ -- On December 5, the 37th "International Volunteer Day", International Volunteer Service Exchange and Sharing Conference was held at the China Plum Art Center, hosted by the International Volunteer Service Working Committee Secretariat of China Volunteer Service Federation and the Civilization Office of Nanjing Municipal People's Government.

Key Points: 
  • NANJING, China, Dec. 15, 2022 /PRNewswire/ -- On December 5, the 37th "International Volunteer Day", International Volunteer Service Exchange and Sharing Conference was held at the China Plum Art Center, hosted by the International Volunteer Service Working Committee Secretariat of China Volunteer Service Federation and the Civilization Office of Nanjing Municipal People's Government.
  • Experts and volunteers from the field of international volunteer service gathered to share stories of voluntary service and contribute their wisdom and efforts to make an exchange platform for international voluntary service.
  • At the same time, Nanjing issued an invitation to the world with "Together, Act Now".
  • "Dedication is one of the most important spirits of international volunteer service, and I am going out on behalf of the motherland.

IEHP Leaders Honored with LLU Alumnus of the Year Awards

Retrieved on: 
Thursday, June 30, 2022
Linda, View, School, United States Public Health Service, Loma Linda University, LLU, Love, Mental health, Anzac of the Year Award, Phạm, Awareness, Public health, Social work, Cal, Loma Linda University School of Public Health, Department of Nutrition, Strategy, Health, LOMA, Leadership, Medicare, Multimedia, Management, Medicine, Medicaid, Inland Empire

Pham earned his master's degree with an emphasis in healthcare administration from LLU's School of Public Health.

Key Points: 
  • Pham earned his master's degree with an emphasis in healthcare administration from LLU's School of Public Health.
  • In this work, Pham constantly seeks new ways for IEHP to better serve the community and its most vulnerable residents.
  • "We were pleased to honor Mr. Thomas Pham with the SPH Alumnus of the Year Award at our 2022 commencement ceremony.
  • Honored by LLU's School of Behavioral Health, Rai graduated with a master's degree in social work.

Oncopole, FRQS cancer division, announces the winners of its "Priorité patient" 2022 Competition

Retrieved on: 
Monday, June 13, 2022
MSD, Loma Linda University School of Public Health, Department of Nutrition, Lung, Enrique Dussel, Animal, Multiple myeloma, Policy, Universitate metro station, Chemoradiotherapy, Aeschynite-(Y), MSSS, Breast, Public, Medicine, Health, Cancer, Center, Anesthesiology, CHUM, CHU, Hypnosis, Partnership, Virtual reality, Part, SSA, Cardiovascular disease, Quality of life, Obesity, Population, HIV, Investor, Heart, Merck, Foreign policy, Department of Oncology, University of Cambridge, MEI, Survivor, School, Vaccine, Prostate, Patient, Association belge des Consommateurs Test-Achats ASBL v Conseil des ministres, Infection, Department, Dysphagia, Life, Head, Program, Research, Science, Intervention, YouTube, Unit, Haematopoietic system, Emotion, Risk, Anatomical pathology, SAN, Sherbrooke, Fonds, Pharmaceutical industry, Dentistry

This competition provides financial support for research projects aimed at improving the care and services for people living with cancer in Quebec.

Key Points: 
  • This competition provides financial support for research projects aimed at improving the care and services for people living with cancer in Quebec.
  • This competition is carried out in collaboration with the Unit de soutien au systme de sant apprenant (SSA) Qubec and the Programme qubcois de cancrologie of the MSSS.
  • The context of the pandemic has highlighted the lack of emotional support for people affected by cancer.
  • Chemoradiotherapy treatments are known to produce significant side effects in people treated for head and neck cancer often leading to swallowing disorders or dysphagia.

NASOYA TO SPONSOR THE CULINARY INSTITUTE OF AMERICA'S GLOBAL PLANT-FORWARD CULINARY SUMMIT

Retrieved on: 
Tuesday, April 19, 2022
Emerald, Zero, Family, BBQ, Buddhism, The Culinary Institute of America, Loma Linda University School of Public Health, Department of Nutrition, Korean, Taste, Wine, Graduate, Culinary Institute, Department, CIA, Harvard T.H. Chan School of Public Health, YouTube, Conference, Food, Copia, Harvard University, Food industry, Agriculture, Cooking, Snack, Honours degree, Meal, School, Instagram, Marketing, Multimedia, Global, Health, Menus, University, Public health, Restaurant, Fast food, Pulmuone, Facebook

AYER, Mass. and FULLERTON, Calif., April 19, 2022 /PRNewswire/ -- Nasoya, the nation's leading brand of tofu and Asian-inspired plant-based foods, announced today it will be showcasing its plant-based innovations at this year's Global Plant-Forward Culinary Summit, presented by The Culinary Institute of America (CIA). Nasoya and its parent company, Pulmuone – one of the largest tofu companies in the world, will serve as Grand Platinum sponsors of the event, taking place April 26 – April 28 at the CIA's Copia campus in Napa, Calif. As leaders in the plant-based movement, the brands' role will help further discussions celebrating the importance of plant-forward cuisine from around the world.

Key Points: 
  • and FULLERTON, Calif., April 19, 2022 /PRNewswire/ -- Nasoya , the nation's leading brand of tofu and Asian-inspired plant-based foods, announced today it will be showcasing its plant-based innovations at this year's Global Plant-Forward Culinary Summit, presented by The Culinary Institute of America (CIA).
  • "The Global Plant-Forward Culinary Summit is an important forum to showcase the impact food can have in bringing together varying cultures and experiences," said Sung Yoon Nam, Vice President of Marketing at Pulmuone.
  • Nasoya and Pulmuone products will be highlighted in sponsored meals, sessions and demonstrations throughout the summit.
  • "Following two years of a virtual format, we are excited to welcome attendees back in person at this year's Global Plant-Forward Culinary Summit," said Rupa Bhattacharya, Executive Director-Strategic Initiatives Group at The Culinary Institute of America.